Mapping ROQUIN-1/RNA interactions in lymphocytes reveals conserved gene regulation targets, suggesting implications for immunity.
Abstract Defining the RNA targets of ROQUIN-1 is essential for understanding post-transcriptional gene regulation in immunity, autoimmunity, and cancer immunotherapy. We systematically mapped transcriptome-wide ROQUIN-1/RNA interactions in mouse and human lymphocytes. Novel targets were enriched in signaling molecules, transcription factors, epigenetic regulators, and mediators of immune cell differentiation. Cross-species analysis revealed conservation at binding sites, suggesting evolutionary preservation of ROQUIN-mediated regulation. Notably, ROQUIN-1 bound all mRNAs of the Id1–Id4 gene family—transcriptional regulators critical for lymphocyte differentiation. Functional perturbation through Id1-3 overexpression impaired thymocyte and B cell development. Similarly, inactivation of Roquin-1/2 increased Id3 expression in thymocytes and developing B cells, delayed double-negative thymocyte progression and blocked B cell development before the pro-B cell stage. Uncovering Roquin's role in controlling gene expression driving lymphocyte development, our dataset also provides a valuable resource for functional genomics to dissect RNA-based regulation in immunity and offers mechanistic insights into ROQUIN function across species.
No takes yet. Share an insight, caveat, or question.
Heissmeyer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: